These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36399111)

  • 1. Optimal Sampling Duration for Continuous Glucose Monitoring for the Estimation of Glycemia Risk Index.
    Shah VN; Sakamoto C; Pyle L
    Diabetes Technol Ther; 2023 Feb; 25(2):140-142. PubMed ID: 36399111
    [No Abstract]   [Full Text] [Related]  

  • 2. Hybrid Closed-Loop Versus Manual Insulin Delivery in Adults With Type 1 Diabetes: A Post Hoc Analysis Using the Glycemia Risk Index.
    Lee MH; Vogrin S; Jones TW; O'Neal DN
    J Diabetes Sci Technol; 2024 Jul; 18(4):764-770. PubMed ID: 38372246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Glycemia Risk Index with Time in Range for Assessing Glycemic Quality.
    Kim JY; Yoo JH; Kim JH
    Diabetes Technol Ther; 2023 Dec; 25(12):883-892. PubMed ID: 37668665
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of Glycemia Risk Index and Standard Continuous Glucose Monitoring Metrics in a Real-World Setting of Exercise in Adults With Type 1 Diabetes: A Post-Hoc Analysis of the Type 1 Diabetes and Exercise Initiative.
    Morrison D; Vogrin S; Zaharieva DP
    J Diabetes Sci Technol; 2024 Jul; 18(4):787-794. PubMed ID: 38629861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation Between the Glycemia Risk Index and Longitudinal Hemoglobin A1c in Children and Young Adults With Type 1 Diabetes.
    Panfil K; Redel JM; Vandervelden CA; Lockee B; Kahkoska AR; Tallon EM; Williams DD; Clements MA
    J Diabetes Sci Technol; 2024 Jul; 18(4):771-778. PubMed ID: 38715286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
    Klonoff DC; Wang J; Rodbard D; Kohn MA; Li C; Liepmann D; Kerr D; Ahn D; Peters AL; Umpierrez GE; Seley JJ; Xu NY; Nguyen KT; Simonson G; Agus MSD; Al-Sofiani ME; Armaiz-Pena G; Bailey TS; Basu A; Battelino T; Bekele SY; Benhamou PY; Bequette BW; Blevins T; Breton MD; Castle JR; Chase JG; Chen KY; Choudhary P; Clements MA; Close KL; Cook CB; Danne T; Doyle FJ; Drincic A; Dungan KM; Edelman SV; Ejskjaer N; Espinoza JC; Fleming GA; Forlenza GP; Freckmann G; Galindo RJ; Gomez AM; Gutow HA; Heinemann L; Hirsch IB; Hoang TD; Hovorka R; Jendle JH; Ji L; Joshi SR; Joubert M; Koliwad SK; Lal RA; Lansang MC; Lee WA; Leelarathna L; Leiter LA; Lind M; Litchman ML; Mader JK; Mahoney KM; Mankovsky B; Masharani U; Mathioudakis NN; Mayorov A; Messler J; Miller JD; Mohan V; Nichols JH; Nørgaard K; O'Neal DN; Pasquel FJ; Philis-Tsimikas A; Pieber T; Phillip M; Polonsky WH; Pop-Busui R; Rayman G; Rhee EJ; Russell SJ; Shah VN; Sherr JL; Sode K; Spanakis EK; Wake DJ; Waki K; Wallia A; Weinberg ME; Wolpert H; Wright EE; Zilbermint M; Kovatchev B
    J Diabetes Sci Technol; 2023 Sep; 17(5):1226-1242. PubMed ID: 35348391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the glycaemia risk index and its association with other continuous glucose monitoring metrics after initiation of an automated insulin delivery system in adults with type 1 diabetes.
    Karakus KE; Shah VN; Klonoff D; Akturk HK
    Diabetes Obes Metab; 2023 Nov; 25(11):3144-3151. PubMed ID: 37427768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemia Risk Index as a Novel Metric to Evaluate the Safety of Glycemic Control in Children and Adolescents with Type 1 Diabetes: An Observational, Multicenter, Real-Life Cohort Study.
    Piona C; Marigliano M; Roncarà C; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Passanisi S; Lombardo F; Bonfanti R; Maffeis C
    Diabetes Technol Ther; 2023 Jul; 25(7):507-512. PubMed ID: 37155332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic Risk Index Profiles and Predictors Among Diverse Adults With Type 1 Diabetes.
    Hoogendoorn CJ; Hernandez R; Schneider S; Harmel M; Pham LT; Crespo-Ramos G; Agarwal S; Crandall J; Peters AL; Spruijt-Metz D; Gonzalez JS; Pyatak EA
    J Diabetes Sci Technol; 2024 Sep; 18(5):1070-1078. PubMed ID: 36999215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Glycemia Risk Index Predicts Performance of Diabetes Self-Management Habits in Youth With Type 1 Diabetes Mellitus.
    Panfil K; Vandervelden CA; Lockee B; Tallon EM; Williams DD; Lee JM
    J Diabetes Sci Technol; 2024 Jul; 18(4):779-786. PubMed ID: 38708581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring.
    Xing D; Kollman C; Beck RW; Tamborlane WV; Laffel L; Buckingham BA; Wilson DM; Weinzimer S; Fiallo-Scharer R; Ruedy KJ;
    Diabetes Technol Ther; 2011 Mar; 13(3):351-8. PubMed ID: 21299401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimum Sampling Duration for Continuous Glucose Monitoring Metrics to Achieve Representative Glycemic Outcomes in Suboptimal Continuous Glucose Monitor Use.
    Akturk HK; Sakamoto C; Vigers T; Shah VN; Pyle L
    J Diabetes Sci Technol; 2023 Sep; ():19322968231200901. PubMed ID: 37747124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics.
    Pérez-López P; Férnandez-Velasco P; Bahillo-Curieses P; de Luis D; Díaz-Soto G
    Endocrine; 2023 Dec; 82(3):560-568. PubMed ID: 37695452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: Determination of optimal sampling duration.
    Piona C; Marigliano M; Mozzillo E; Franzese A; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
    Pediatr Diabetes; 2020 Dec; 21(8):1485-1492. PubMed ID: 32935887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between glycemia risk index and arterial stiffness in type 2 diabetes.
    Cai L; Shen W; Li J; Wang B; Sun Y; Chen Y; Gao L; Xu F; Xiao X; Wang N; Lu Y
    J Diabetes Investig; 2024 May; 15(5):614-622. PubMed ID: 38251792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Advanced Hybrid Closed Loop Improves Glycemia Risk Index, Continuous Glucose Monitoring Index, and Time in Range in Children with Type 1 Diabetes: Real-World Data from a Single Center Study.
    Eviz E; Yesiltepe Mutlu G; Karakus KE; Can E; Gokce T; Muradoglu S; Hatun S
    Diabetes Technol Ther; 2023 Oct; 25(10):689-696. PubMed ID: 37449922
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control.
    Riddlesworth TD; Beck RW; Gal RL; Connor CG; Bergenstal RM; Lee S; Willi SM
    Diabetes Technol Ther; 2018 Apr; 20(4):314-316. PubMed ID: 29565197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycaemia risk index uncovers distinct glycaemic variability patterns associated with remission status in type 1 diabetes.
    Zhong T; He B; Li X; Lei K; Tang R; Zhao B; Li X
    Diabetologia; 2024 Jan; 67(1):42-51. PubMed ID: 37889319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Different Types of Data Loss on Optimal Continuous Glucose Monitoring Sampling Duration.
    Akturk HK; Herrero P; Oliver N; Wise H; Eikermann E; Snell-Bergeon J; Shah VN
    Diabetes Technol Ther; 2022 Oct; 24(10):749-753. PubMed ID: 35653736
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors associated with Glycemia Risk Index in a cohort of patients with type 1 Diabetes Mellitus and Latent Autoimmune Diabetes In Adults (LADA).
    Herranz-Antolín S; Cotón-Batres C; López-Virgos MC; Esteban-Monge V; Álvarez-de Frutos V; Torralba M
    Endocrine; 2024 Nov; 86(2):574-583. PubMed ID: 38844609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.